{"id":"https://openalex.org/W4322769732","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p6-01-38","title":"Abstract P6-01-38: Predictive efficacy biomarker for chemotherapy agents against triple-negative breast cancer bioprinted organoid tumors (BOTs) using solid tumor biopsy-on-a-chip","display_name":"Abstract P6-01-38: Predictive efficacy biomarker for chemotherapy agents against triple-negative breast cancer bioprinted organoid tumors (BOTs) using solid tumor biopsy-on-a-chip","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322769732","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p6-01-38"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs22-p6-01-38","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p6-01-38","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs22-p6-01-38","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046389680","display_name":"Seth Bollenbecker","orcid":"https://orcid.org/0000-0001-5536-2744","observed_orcids":["https://orcid.org/0000-0001-5536-2744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth Bollenbecker","raw_affiliation_strings":["1CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CerFlux, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049338617","display_name":"Zeelu H. Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeelu Patel","raw_affiliation_strings":["2CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CerFlux, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084185889","display_name":"Zeenia Punjani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zeenia Punjani","raw_affiliation_strings":["3CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3CerFlux, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008948468","display_name":"Areesha A. Charania","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Areesha Charania","raw_affiliation_strings":["4CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CerFlux, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heli Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heli Patel","raw_affiliation_strings":["5CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5CerFlux, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alyssa Abbott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405256108","display_name":"Precision Ocular Network","ror":"https://ror.org/03s9qe417","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405256108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alyssa Abbott","raw_affiliation_strings":["6Advancing SIght Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Advancing SIght Network","institution_ids":["https://openalex.org/I4405256108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058584750","display_name":"Kaitlyn Kunkle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405256108","display_name":"Precision Ocular Network","ror":"https://ror.org/03s9qe417","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405256108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn Kunkle","raw_affiliation_strings":["7Advancing Sight Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Advancing Sight Network","institution_ids":["https://openalex.org/I4405256108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061863817","display_name":"Mary Kathryn Sewell-Loftin","orcid":"https://orcid.org/0000-0003-1985-6899","observed_orcids":["https://orcid.org/0000-0003-1985-6899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Kathryn Sewell-Loftin","raw_affiliation_strings":["8CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8CerFlux, Inc","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047055975","display_name":"Gregory Grossman","orcid":"https://orcid.org/0000-0003-1511-7028","observed_orcids":["https://orcid.org/0000-0003-1511-7028"]},"institutions":[{"id":"https://openalex.org/I4405256108","display_name":"Precision Ocular Network","ror":"https://ror.org/03s9qe417","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405256108"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Grossman","raw_affiliation_strings":["9Advancing Sight Network"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Advancing Sight Network","institution_ids":["https://openalex.org/I4405256108"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044188184","display_name":"Karim I. Budhwani","orcid":"https://orcid.org/0000-0001-8823-1695","observed_orcids":["https://orcid.org/0000-0001-8823-1695"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karim Budhwani","raw_affiliation_strings":["10CerFlux, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10CerFlux, Inc","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"5_Supplement","first_page":"P6","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11190","display_name":"3D Printing in Biomedical Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10412","display_name":"Microfluidic and Capillary Electrophoresis Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7300000190734863},{"id":"https://openalex.org/keywords/calcium-chloride-crosslinking","display_name":"calcium chloride crosslinking","score":0.8539999723434448},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.902999997138977},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.5509999990463257},{"id":"https://openalex.org/keywords/patient-derived-tumor-models","display_name":"patient-derived tumor models","score":0.6159999966621399},{"id":"https://openalex.org/keywords/ex-vivo-drug-screening","display_name":"ex vivo drug testing","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8614248633384705},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.8327018022537231},{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.651315450668335},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6220576167106628},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.5678200721740723},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5590735077857971},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5279340147972107},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.47569096088409424},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47186630964279175},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4500772953033447},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.4327351450920105},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4243926405906677},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3917492628097534},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.19290092587471008},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1799640655517578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16568288207054138},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs22-p6-01-38","doi":"https://doi.org/10.1158/1538-7445.sabcs22-p6-01-38","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs22-p6-01-38","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281671283","https://openalex.org/W4386864640","https://openalex.org/W2955828890","https://openalex.org/W7170304629","https://openalex.org/W4391091329","https://openalex.org/W7128601837","https://openalex.org/W7130709481","https://openalex.org/W4281957573","https://openalex.org/W7211935647","https://openalex.org/W4413800376"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Despite":[2],"$90":[3],"billion":[4],"in":[5,25,33,82,99,131,168,185,204,337,405],"preclinical":[6,30],"research":[7],"and":[8,55,65,135,183,190,211,219,227,243,264,316,331,348,364,380,386,392],"clinical":[9,16,27],"trials":[10,17],"every":[11],"year,":[12],"90%":[13],"of":[14,29,116,197,254,298,305,383,453],"cancer":[15,341,407,441],"are":[18],"unsuccessful.":[19],"Thus,":[20],"there":[21],"is":[22,80,119],"considerable":[23],"interest":[24],"predicting":[26],"efficacy":[28,274,401,433],"formulations":[31],"early":[32],"discovery":[34],"using":[35,145,162,224,291,446],"patient":[36,61],"derived":[37,327],"ex":[38,100,132,206,270,338],"vivo":[39,101,133,207,271,339],"platforms.":[40],"However,":[41,67],"extracting":[42],"adequate":[43],"tissue":[44,62,128,308],"for":[45,59,92,97,129,139,248,266,359,435],"such":[46],"models":[47,344],"can":[48,396],"be":[49,260,282,335],"difficult":[50],"depending":[51],"on":[52,356,365],"tumor":[53,177,209,385,448],"type":[54],"site.":[56],"Dominant":[57],"mechanisms":[58],"expanding":[60,93],"include":[63],"xenografts":[64],"organoids.":[66],"the":[68,78,261,286,306,357,366,454],"former":[69],"imposes":[70],"a":[71,89,163,241,384],"large":[72],"time":[73,236],"window":[74],"to":[75,120,171,174,187,192,216,259,281,301,321,345,368,374,377,404],"establish":[76],"while":[77],"latter":[79],"constrained":[81],"space":[83],"by":[84],"sizescales.":[85],"Here,":[86],"we":[87],"present":[88],"novel":[90],"approach":[91],"TNBC":[94,122,151,157,255,277],"tissue,":[95],"specifically":[96],"use":[98,130],"models,":[102],"that":[103,124],"addresses":[104],"these":[105],"constrains":[106],"with":[107,149,194,213,221,237,268,311],"3D":[108],"bioprinted":[109,307,442],"organoid":[110,443],"tumors":[111,444],"(BOTs).":[112],"Objective:":[113],"The":[114],"aim":[115],"this":[117],"study":[118],"generate":[121],"BOTs":[123,142,201],"mimic":[125,172],"core":[126,329],"biopsy":[127],"precision":[134,391],"personalized":[136,360,393],"predictive":[137,273,352],"biomarkers":[138,354],"chemotherapies.":[140],"Methods:":[141],"were":[143,180,202,279],"generated":[144],"alginate-based":[146],"bioink":[147,158,256],"prepared":[148,155],"MDA-MB-231":[150],"cells.":[152],"Briefly,":[153],"specially":[154],"fresh":[156],"was":[159,257,309],"deposited":[160],"layer-by-layer":[161],"Cellink":[164],"BIO":[165],"X6":[166],"bioprinter":[167],"geometrical":[169],"configurations":[170,333],"14-":[173],"18-":[175],"gauge":[176],"biopsies.":[178],"These":[179],"chemically":[181],"cross-linked":[182],"cured":[184,200,287],"stages":[186],"allow":[188],"cells":[189,278],"matrix":[191,290],"self-assemble":[193],"limited":[195],"degrees":[196],"freedom.":[198],"Fully":[199],"loaded":[203],"our":[205,269],"solid":[208,447],"biopsy-on-a-chip":[210,272,449],"treated":[212],"chemotherapy":[214,342,436],"agents":[215,300,437],"evaluate":[217],"sensitivity":[218,347],"resistance,":[220],"outcomes":[222],"determined":[223,258],"immunofluorescent":[225],"live":[226,292],"dead":[228],"cell":[229,293],"staining":[230],"methods.":[231],"Results:":[232],"A":[233],"3-minute":[234],"crosslinking":[235],"calcium":[238],"chloride":[239],"provided":[240],"stable":[242],"functional":[244,353],"sodium":[245,288],"alginate":[246,289],"medium":[247],"treating":[249],"cellular":[250],"BOTs.":[251],"Two":[252],"layers":[253],"optimal":[262],"size":[263],"shape":[265],"compatibility":[267],"biomarker":[275,434],"platform.":[276],"verified":[280,310],"evenly":[283],"distributed":[284],"within":[285],"nuclear":[294],"stains.":[295],"Successful":[296],"diffusion":[297],"multiple":[299],"spatially":[302],"distinct":[303],"regions":[304],"fluorescently":[312],"labeled":[313],"small":[314],"molecules":[315],"nucleic":[317],"acid":[318],"stains":[319],"up":[320],"200":[322],"\u00b5M":[323],"deep.":[324],"Impact:":[325],"Patient":[326],"BOT":[328,389],"mimics":[330],"other":[332],"could":[334],"used":[336],"breast":[340,440],"screening":[343],"obtain":[346],"resistance":[349],"profiles":[350],"as":[351],"both":[355],"bedside":[358],"treatment":[361],"strategy":[362],"development":[363],"bench":[367],"uncover":[369],"new":[370],"therapeutic":[371],"targets.":[372],"Due":[373],"their":[375],"potential":[376],"replicate":[378],"biophysical":[379],"biochemical":[381],"characteristics":[382],"its":[387],"microenvironment,":[388],"based":[390],"medicine":[394],"platforms":[395],"provide":[397],"more":[398],"accurate":[399],"drug":[400],"readout":[402],"compared":[403],"vitro":[406],"models.":[408],"Citation":[409],"Format:":[410],"Seth":[411],"Bollenbecker,":[412],"Zeelu":[413],"Patel,":[414,420],"Zeenia":[415],"Punjani,":[416],"Areesha":[417],"Charania,":[418],"Heli":[419],"Alyssa":[421],"Abbott,":[422],"Kaitlyn":[423],"Kunkle,":[424],"Mary":[425],"Kathryn":[426],"Sewell-Loftin,":[427],"Gregory":[428],"Grossman,":[429],"Karim":[430],"Budhwani.":[431],"Predictive":[432],"against":[438],"triple-negative":[439],"(BOTs)":[445],"[abstract].":[450],"In:":[451],"Proceedings":[452],"2022":[455,461],"San":[456,464],"Antonio":[457],"Breast":[458],"Cancer":[459,470],"Symposium;":[460],"Dec":[462],"6-10;":[463],"Antonio,":[465],"TX.":[466],"Philadelphia":[467],"(PA):":[468],"AACR;":[469],"Res":[471],"2023;83(5":[472],"Suppl):Abstract":[473],"nr":[474],"P6-01-38.":[475]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-03-03T00:00:00"}